Latest

The $35 million deal with Mallinckrodt Pharmaceuticals requires the company to take further steps in reporting suspicious orders of its drugs.

  • Jul 11, 2017

After years of government and pharmaceutical firms failing to control the problem, some lawyers say the suits have the potential to force the industry to curb practices that contribute to it.

  • Jul 4, 2017

The committee wants to know how so many drugs hit the street and why the DEA slowed enforcement.

  • May 11, 2017

His draft plan eliminates nearly 95 percent of the agency’s budget and zeros out two key programs.

  • May 5, 2017

A landmark suit alleges that distributors and pharmacies turned a blind eye to drug damage.

  • Apr 20, 2017

“They just weren’t taking this seriously, and people were dying.”

  • Apr 2, 2017

Sen. Claire McCaskill alleges that the epidemic is the result of a “calculated sales and marketing strategy.“

  • Mar 28, 2017

The lawsuits name McKesson, Cardinal Health. AmerisourceBergen, Walgreens, CVS and others.

  • Mar 9, 2017

Sen. Claire McCaskill asked the Justice Department’s inspector general to investigate the agency’s slowed response.

  • Mar 6, 2017

They called the agency’s responses to a Washington Post series “insufficient.”

  • Jan 18, 2017
Load More